scholarly article | Q13442814 |
P50 | author | Douglas G. Altman | Q5300242 |
P2093 | author name string | An-Wen Chan | |
P2860 | cites work | The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials | Q28185637 |
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research | Q28285027 | ||
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles | Q29618882 | ||
Meta-analyses involving cross-over trials: methodological issues | Q29620304 | ||
Better reporting of harms in randomized trials: an extension of the CONSORT statement | Q33983100 | ||
Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed | Q34577274 | ||
Registration of trials and protocols | Q35548815 | ||
Bias in meta-analytic research | Q43559593 | ||
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis | Q50141599 | ||
Explaining heterogeneity in meta-analysis: a comparison of methods | Q52141807 | ||
False-positive results in clinical trials: multiple significance tests and the problem of unreported comparisons | Q52310305 | ||
Investigation of within-study selective reporting in clinical research: follow-up of applications submitted to a local research ethics committee | Q52941855 | ||
Role of the pharmaceutical industry in major clinical trials | Q69909359 | ||
Withholding research results in academic life science. Evidence from a national survey of faculty | Q73224477 | ||
The adequacy of reporting randomized, controlled trials in the evaluation of antidepressants | Q77735182 | ||
How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing | Q78171131 | ||
Epidemiology and reporting of randomised trials published in PubMed journals | Q81584040 | ||
P433 | issue | 7494 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | PubMed | Q180686 |
bias | Q742736 | ||
P304 | page(s) | 753 | |
P577 | publication date | 2005-01-28 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors | |
P478 | volume | 330 |
Q30552717 | "Hardly worth the effort"? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: quantitative and qualitative study |
Q90179312 | A comparative study to evaluate quality of data documentation between investigator-initiated and pharmaceutical industry-sponsored studies |
Q56897213 | A duty to participate in research: does social context matter? |
Q38287843 | A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials |
Q92515344 | A protocol developing, disseminating and implementing a core outcome set for infertility |
Q53113773 | A reader responds to "The myth of equipoise in phase 1 clinical trials". |
Q51024831 | A selection model for accounting for publication bias in a full network meta-analysis |
Q92219370 | A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain |
Q34438661 | A systematic review of randomised controlled trials of interventions promoting effective condom use. |
Q64948250 | A systematic review of specialist inpatient dementia care services versus standard inpatient dementia care in acute hospitals. |
Q28472665 | A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children |
Q43160307 | Abstracts in high profile journals often fail to report harm |
Q33378465 | African HIV/AIDS trials are more likely to report adequate allocation concealment and random generation than North American trials |
Q39305054 | Age-Related Patterns in Cancer Pain and Its Psychosocial Impact: Investigating the Role of Variability in Physical and Mental Health Quality of Life |
Q37863701 | Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis |
Q24234305 | Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia (ALL) in first complete remission |
Q24235952 | Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission |
Q34939554 | Analgesic efficacy of opioids in chronic pain: recent meta-analyses |
Q24240612 | Antibiotics and antiseptics for venous leg ulcers |
Q24242699 | Antibiotics and antiseptics for venous leg ulcers |
Q24235796 | Antioxidant supplements for liver diseases |
Q24242191 | Antioxidant supplements for preventing gastrointestinal cancers |
Q24245704 | Antioxidant supplements for preventing gastrointestinal cancers |
Q37730441 | Are outcomes reported in surgical randomized trials patient-important? A systematic review and meta-analysis |
Q30485022 | Assessing the risk of bias in randomized controlled trials in the field of dentistry indexed in the Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde) database |
Q42379732 | Assessment of risk of bias in quasi-randomized controlled trials and randomized controlled trials reported in the Korean Journal of Anesthesiology between 2010 and 2016. |
Q24289437 | Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations |
Q89497003 | Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT) |
Q24288921 | Association of trial registration with the results and conclusions of published trials of new oncology drugs |
Q24288823 | Attenti alle bufale ("beware of red herrings"), or, how to make evidence-based medicine work for you |
Q55475456 | Avoidable waste of research related to outcome planning and reporting in clinical trials. |
Q42122297 | Believability of relative risks and odds ratios in abstracts: cross sectional study |
Q36416843 | Bench to bedside: the quest for quality in experimental stroke research |
Q38623830 | Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials |
Q24244930 | Benzodiazepines for neuroleptic-induced tardive dyskinesia |
Q24193207 | Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions |
Q24198908 | Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions |
Q92969057 | Bias in clinical trials into the effects of complementary and alternative medicine therapies on hemodialysis patients |
Q38133728 | Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales |
Q26796256 | Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer |
Q33316156 | CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration |
Q37117080 | Calibration of credibility of agnostic genome-wide associations |
Q93188078 | Causes of reporting bias: a theoretical framework |
Q38663710 | Change in physical activity from adolescence to early adulthood: a systematic review and meta-analysis of longitudinal cohort studies. |
Q94545005 | Chinese Taoist Cognitive Therapy for Symptoms of Depression and Anxiety in Adults in China: A Systematic Review and Meta-Analysis |
Q35805116 | Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention |
Q46584339 | Clinical trial registration at Tobacco Control. |
Q86499109 | Clinical trials submitted to the JID: place your bet and show us your hand |
Q24188088 | Cognitive behavioural therapy for anxiety disorders in children and adolescents |
Q24202314 | Cognitive behavioural therapy for anxiety disorders in children and adolescents |
Q24235035 | Comparison of protocols and registry entries to published reports for randomised controlled trials |
Q26783379 | Complementary and Alternative Medicine for the Management of Cervical Radiculopathy: An Overview of Systematic Reviews |
Q24194968 | Complementary therapies for chronic plaque psoriasis |
Q38150483 | Consistency and completeness of reported outcomes in randomized trials of primary immunosuppression in kidney transplantation |
Q37967678 | Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review |
Q37980890 | Conversion rates of abstracts presented at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting into full-text journal articles. |
Q46170421 | Core outcome measures in perioperative and anaesthetic care. |
Q47158367 | Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer |
Q30650486 | Data collection in cancer clinical trials: Too much of a good thing? |
Q37332662 | Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles |
Q48105455 | Determinants of selective reporting: A taxonomy based on content analysis of a random selection of the literature |
Q36498619 | Developing a guideline for clinical trial protocol content: Delphi consensus survey |
Q37279152 | Development of a core outcome set for research and audit studies in reconstructive breast surgery. |
Q33375845 | Diabetes experts' reasoning about diabetes prevention studies: a questionnaire survey |
Q35774634 | Discrepancies in Outcome Reporting Exist Between Protocols and Published Oral Health Cochrane Systematic Reviews |
Q55025094 | Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis. |
Q28475991 | Doctors and Drug Companies: Still Cozy after All These Years |
Q36635523 | Economic evaluations in the canadian common drug review |
Q53078875 | Editorial bias in scientific publications |
Q92237045 | Effects of cannabinoid administration for pain: A meta-analysis and meta-regression |
Q34656488 | Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis. |
Q36125353 | Efficacy of cognitive enhancers for Alzheimer's disease: protocol for a systematic review and network meta-analysis |
Q30357430 | Emotion felt by the listener and expressed by the music: literature review and theoretical perspectives. |
Q35060093 | Empirical evidence for outcome reporting bias in randomized clinical trials of acupuncture: comparison of registered records and subsequent publications |
Q94546137 | Ensuring young voices are heard in core outcome set development: international workshops with 70 children and young people |
Q33521365 | Estimating required information size by quantifying diversity in random-effects model meta-analyses. |
Q33751652 | Evidence of selective reporting bias in hematology journals: A systematic review |
Q24288780 | Evolution and translation of research findings: from bench to where? |
Q36584276 | Exercise and Bone Mineral Density in Premenopausal Women: A Meta-Analysis of Randomized Controlled Trials |
Q30920608 | Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies |
Q21563421 | Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others |
Q42940771 | Financial ties that might bind: Delve deeper to find the links |
Q33787792 | Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists |
Q53184205 | Full disclosure--nothing less will do. |
Q57338290 | GRADE-Leitlinien: 4. Bewertung der Qualität der Evidenz – Studienlimitationen (Risiko für Bias) |
Q37454595 | Gabapentinoids for chronic low back pain: a protocol for systematic review and meta-analysis of randomised controlled trials |
Q34163883 | Global Distribution of Outbreaks of Water-Associated Infectious Diseases |
Q40284634 | Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). |
Q46108878 | Guarding Against Overtesting, Overdiagnosis, and Overtreatment of Older Adults: Thinking Beyond Imaging and Injuries to Weigh Harms and Benefits |
Q64247117 | Guidance for reporting outcomes in clinical trials: scoping review protocol |
Q36498818 | Guidelines for randomized clinical trial protocol content: a systematic review |
Q24241852 | Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status |
Q35943880 | How do authors of systematic reviews deal with research malpractice and misconduct in original studies? A cross-sectional analysis of systematic reviews and survey of their authors |
Q35211265 | How electronic clinical data can improve health technology assessment |
Q53750741 | How to design a randomised controlled trial |
Q35151458 | Impact of inclusion of industry trial results registries as an information source for systematic reviews |
Q64060254 | Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT) |
Q58054154 | Improving the Reporting of Health and Psychological Research |
Q28474828 | Inadequate dissemination of phase I trials: a retrospective cohort study |
Q24240883 | Increased police patrols for preventing alcohol-impaired driving |
Q28611347 | Increasing value and reducing waste: addressing inaccessible research |
Q35158628 | Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis |
Q37572176 | Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses |
Q35810253 | Interpretation of Results of Studies Evaluating an Intervention Highlighted in Google Health News: A Cross-Sectional Study of News |
Q37329334 | Interpretation of tests of heterogeneity and bias in meta-analysis |
Q26738749 | Interventions for compassionate nursing care: A systematic review |
Q38520309 | Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions |
Q33588182 | Legislation for trial registration and data transparency |
Q28069582 | Local anesthetic injections with or without steroid for chronic non-cancer pain: a protocol for a systematic review and meta-analysis of randomized controlled trials |
Q37027983 | MOMENT--Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. |
Q35811280 | Mail merge can be used to create personalized questionnaires in complex surveys |
Q49843236 | Management of medial humeral epicondyle fractures in children: a structured review protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. |
Q38973072 | Management of non-syndromic dens evaginatus affecting permanent maxillary central incisors: a systematic review |
Q38866484 | Management of non-syndromic double tooth affecting permanent maxillary central incisors: a systematic review. |
Q54942333 | Many Flavors of Model-Based Meta-Analysis: Part II - Modeling Summary Level Longitudinal Responses. |
Q57318061 | Medical editors and trial reporting: a betrayal of patient care |
Q53278031 | Meta-research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust |
Q38031911 | Meta‐analysis in context |
Q37008455 | Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls |
Q24240125 | Milnacipran versus other antidepressive agents for depression |
Q37765079 | Modified intention to treat reporting in randomised controlled trials: systematic review |
Q24597537 | Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study |
Q28538894 | Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis |
Q33758588 | Obstacles to researching the researchers: a case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials |
Q93129503 | Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events |
Q24289273 | Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov |
Q28598096 | Outcome Reporting Bias in Government-Sponsored Policy Evaluations: A Qualitative Content Analysis of 13 Studies |
Q52714553 | Outcome pre-specification requires sufficient detail to guard against outcome switching in clinical trials: a case study |
Q42257138 | Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs |
Q97527212 | Outcome reporting recommendations for clinical trial protocols and reports: a scoping review |
Q36296533 | Outcome selection bias in meta-analysis |
Q35347819 | Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability. |
Q35994171 | Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis |
Q42374395 | Patient safety requires a new way to publish clinical trials |
Q64928193 | Peer reviewed evaluation of registered end-points of randomised trials (the PRE-REPORT study): protocol for a stepped-wedge, cluster-randomised trial. |
Q37513556 | Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus |
Q24632541 | Peripheral biomarkers of endometriosis: a systematic review |
Q36000225 | Planning and reporting of quality-of-life outcomes in cancer trials. |
Q24246026 | Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients |
Q38668319 | Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients |
Q36300403 | Post-stroke self-management interventions: a systematic review of effectiveness and investigation of the inclusion of stroke survivors with aphasia |
Q24289045 | Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study |
Q28654786 | Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey |
Q36104338 | Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). |
Q30528845 | Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review |
Q37029960 | Prospective registration, bias risk and outcome-reporting bias in randomised clinical trials of traditional Chinese medicine: an empirical methodological study |
Q56880296 | Protocols, probity, and publication |
Q38108574 | Publication Bias, with a Focus on Psychiatry: Causes and Solutions |
Q37520828 | Publication bias and the canonization of false facts |
Q34476958 | Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews |
Q33262004 | Publishing clinical trial results: the future beckons |
Q46443569 | Quality of Registration for Clinical Trials Published in Emergency Medicine Journals |
Q38096481 | Quality of reporting and its correlates among randomized controlled trials on acupuncture for cancer pain: application of the CONSORT 2010 Statement and STRICTA. |
Q37894671 | Quality of reporting in randomized controlled trials conducted in China on the treatment of cancer pain |
Q55379543 | Quality of reporting web-based and non-web-based survey studies: What authors, reviewers and consumers should consider. |
Q35088375 | Quantifying bias in randomized controlled trials in child health: a meta-epidemiological study |
Q64971091 | RADIATE - Radial Dysplasia Assessment, Treatment and Aetiology: protocol for the development of a core outcome set using a Delphi survey. |
Q38571344 | Randomized controlled trials and neuro-oncology: should alternative designs be considered? |
Q91524859 | Randomized controlled trials on erectile dysfunction: quality assessment and relevant clinical impact (2007-2018) |
Q90452396 | Recommendations for Increasing the Transparency of Analysis of Preexisting Data Sets |
Q90382979 | Registration and Outcome-Reporting Bias in Randomized Controlled Trials of Distal Radial Fracture Treatment |
Q37066032 | Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review |
Q21203744 | Reporting bias in medical research - a narrative review |
Q37071333 | Reporting characteristics of non-primary publications of results of randomized trials: a cross-sectional review |
Q37072945 | Reporting of clinical trials: a review of research funders' guidelines |
Q38185927 | Reporting of sources of funding in systematic reviews in periodontology and implant dentistry |
Q37756241 | Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review |
Q38189499 | Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies |
Q38547161 | Risk of bias and magnitude of effect in orthodontic randomized controlled trials: a meta-epidemiological review. |
Q34102963 | Risk of bias tool in systematic reviews/meta-analyses of acupuncture in Chinese journals |
Q42081186 | Risk of bias versus quality assessment of randomised controlled trials: cross sectional study |
Q24240095 | Risperidone dose for schizophrenia |
Q56565523 | STrengthening the REporting of Genetic Association Studies (STREGA)-an extension of the STROBE statement |
Q33405556 | STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement |
Q37314650 | STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement |
Q81156081 | Safety of influenza vaccines in children |
Q51319344 | Scientific Reporting: Raising the Standards. |
Q48094039 | Searching for trial protocols: A comparison of methods |
Q26851180 | Selecting and measuring optimal outcomes for randomised controlled trials in surgery |
Q57278238 | Selective outcome reporting: telling and detecting true lies. The state of the science |
Q36465424 | Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review. |
Q40657294 | Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study |
Q28750315 | Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study |
Q38625478 | Sponsorship bias and quality of randomised controlled trials in veterinary medicine. |
Q26851473 | Standard 2: Containing Risk of Bias |
Q26864374 | Statistical and methodological considerations for reporting RCTs in medical literature |
Q24236219 | Strategies for improving the acceptability and acceptance of the copper intra-uterine device |
Q24201234 | Strategies for improving the acceptability and acceptance of the copper intrauterine device |
Q56565671 | Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement |
Q56565716 | Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement |
Q35869658 | Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis. |
Q38193965 | Systematic review and meta-analysis of psychological therapies for children with chronic pain. |
Q37191497 | Systematic review of knowledge translation strategies in the allied health professions |
Q29619094 | Systematic review of the empirical evidence of study publication bias and outcome reporting bias |
Q38669958 | Systematic review: Outcome reporting bias is a problem in high impact factor neurology journals |
Q37435503 | Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes. |
Q21092360 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration |
Q27860581 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration |
Q24282603 | The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey |
Q36095314 | The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies |
Q38141169 | The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration |
Q52562524 | The over-representation of significant p values in abstracts compared to corresponding full texts: A systematic review of surgical randomized trials |
Q42940808 | The relation between publication bias and clinical trials funding |
Q35155135 | The reporting of observational clinical functional magnetic resonance imaging studies: a systematic review |
Q37641067 | The use of older studies in meta-analyses of medical interventions: a survey. |
Q28535706 | Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals |
Q50160426 | Trends in endpoint selection in clinical trials of advanced breast cancer |
Q42519635 | Trial protocols at the BMJ. |
Q90458774 | Trial registration as a safeguard against outcome reporting bias and spin? A case study of randomized controlled trials of acupuncture |
Q24289436 | Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis |
Q26864790 | Typology of the primary outcome construction in dermatology: a systematic review of published randomized controlled trials |
Q38121661 | US Food and Drug Administration documents can provide unpublished evidence relevant to systematic reviews |
Q24289257 | US studies may overestimate effect sizes in softer research |
Q51497688 | Understanding of diabetes prevention studies: questionnaire survey of professionals in diabetes care |
Q24194619 | Universal community-based social development interventions for preventing community violence by young people 12 to 18 years of age |
Q94327976 | Universal community‐based social development interventions for preventing community violence by young people 12 to 18 years of age |
Q38726201 | Variations in reporting of outcomes in randomized trials on diet and physical activity in pregnancy: A systematic review. |
Q35431427 | What affects authors' and editors' use of reporting guidelines? Findings from an online survey and qualitative interviews |
Q37677188 | What do clinical trials tell us about treating patients? |
Q48582153 | Why Ineffective Psychotherapies Appear to Work: A Taxonomy of Causes of Spurious Therapeutic Effectiveness |
Q83576948 | [The importance of analysis in published evidence levels] |
Search more.